Using the andersen healthcare utilization model to assess willingness to screen for prep in pharmacy-based settings among cisgender sexually minoritized men: results from the 2020 american men’s internet survey | BMC Public Health
Centers for Disease Control and Prevention. HIV PrEP effectiveness. Available from: https://www.cdc.gov/hiv/basics/prep/prep-effectiveness.html.
Huang Ylin, Zhu A, Smith W, Harris DK, Hoover N. HIV preexposure prophylaxis, by race and ethnicity — United States, 2014–2016. MMWR Morb Mortal Wkly Rep. 2019;67(41):1147–50.
Google Scholar
Fanfair RN, Mermin JH. Expanding PrEP coverage in the United States to achieve EHE goals. 2024. Available from: Cited 2024 Jun 11.
Kanny D, Jeffries WL, Chapin-Bardales J, Denning P, Cha S, Finlayson T, et al. Racial/ethnic disparities in HIV preexposure prophylaxis among men who have sex with men — 23 urban areas, 2017. MMWR Morb Mortal Wkly Rep. 2019;68(37):801–6.
Google Scholar
Harrington KRV, Chandra C, Alohan DI, Cruz D, Young HN, Siegler AJ, et al. Examination of HIV preexposure prophylaxis need, availability, and potential pharmacy integration in the southeastern US. JAMA Netw Open. 2023;6(7):e2326028.
Google Scholar
Siegler AJ, Bratcher A, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health. 2019;109(9):1216–23.
Google Scholar
Sharpe JD, Sanchez TH, Siegler AJ, Guest JL, Sullivan PS. Association between the geographic accessibility of PrEP and PrEP use among MSM in nonurban areas. J Rural Health. 2022;38(4):948–59.
Google Scholar
Storholm ED, Ober AJ, Mizel ML, Matthews L, Sargent M, Todd I, et al. Primary care providers’ knowledge, attitudes and beliefs about HIV pre-exposure prophylaxis (PrEP): informing network-based interventions. AIDS Educ Prev. 2021;33(4):325–44.
Google Scholar
Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778–811.
Google Scholar
Crawford ND, Myers S, Young H, Klepser D, Tung E. The role of pharmacies in the HIV prevention and care continuums: a systematic review. AIDS Behav. 2021;25(6):1819–28.
Google Scholar
Rathbun RC, Durham SH, Farmer KC, Zuckerman AD, Badowski ME. Evaluation of human immunodeficiency virus curricular content in schools of pharmacy in the United States. Curr Pharm Teach Learn. 2020;12(8):910–7.
Google Scholar
Crawford ND, Josma D, Morris J, Hopkins R, Young HN. Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men. J Am Pharm Associ. 2020;60(4):602–8.
Google Scholar
Crawford ND, Dean T, Rivera AV, Guffey T, Amesty S, Rudolph A, et al. Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach. Public Health Repo. 2016;131 Suppl(Suppl 1):139–46.
Google Scholar
Alohan DI, Evans G, Sanchez T, Harrington KRV, Quamina A, Young HN, et al. Examining pharmacies’ ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States. J Am Pharmacists Association. 2023;63(2):547–54.
Google Scholar
Glanz K, Bishop DB. The role of behavioral science theory in development and implementation of public health interventions. Annu Rev Public Health. 2010;31:399–418.
Google Scholar
Noar SM, Zimmerman RS. Health behavior theory and cumulative knowledge regarding health behaviors: are we moving in the right direction? Health Educ Res. 2005;20(3):275–90.
Google Scholar
Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36(1):1–10 Published by : American Sociological Association Stable URL : Revisiting the Behavioral Model and Access to Medical Care : Does It Matter?*.
Google Scholar
Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s behavioral model of health services use: a systematic review of studies from 1998–2011. Psychosoc Med. 2012;9:Doc11.
Google Scholar
Phillips KA, Morrison KR, Andersen R, Aday LA. Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res. 1998;33(3 Pt 1):571–96.
Google Scholar
Wiatrek S, Zlotorzynska M, Rai R, Sullivan P, Sanchez T. The annual American men’s internet survey of behaviors of men who have sex with men in the United States: key indicators report 2018. JMIR Public Health Surveill. 2021;7(3):e21812–e21812 https://publichealth.jmir.org/2021/3/e21812.
Google Scholar
Sperandei S. Understanding logistic regression analysis. Biochem Med (Zagreb). 2014;24(1):12–8.
Google Scholar
Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20(5):731–9.
Google Scholar
Wong GY, Mason WM. The hierarchical logistic regression model for multilevel analysis. J Am Stat Assoc. 1985;80(391):513–24.
Google Scholar
Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(1):1–13.
Google Scholar
Sullivan PS, Sanchez TH, Zlotorzynska M, Chandler CJ, Sineath R, Kahle E, et al. National trends in HIV pre-exposure prophylaxis awareness, willingness and use among United States men who have sex with men recruited online, 2013 through 2017. J Int AIDS Soc. 2020;23(3): e25461.
Google Scholar
Levy ME, Wilton L, Phillips G, Glick SN, Kuo I, Brewer RA, et al. Understanding structural barriers to accessing HIV testing and prevention services among black men who have sex with men (BMSM) in the United States. AIDS Behav. 2014;18(5):972–96.
Google Scholar
Babel RA, Wang P, Alessi EJ, Raymond HF, Wei C. Stigma, HIV risk, and access to HIV prevention and treatment services among men who have sex with men (MSM) in the United States: a scoping review. AIDS Behav. 2021;25(11):3574–604.
Google Scholar
Quinn K, Bowleg L, Dickson-Gomez J. “The fear of being Black plus the fear of being gay”: the effects of intersectional stigma on PrEP use among young Black gay, bisexual, and other men who have sex with men. Soc Sci Med. 2019;232:86–93.
Google Scholar
Lutz S, Heberling M, Goodlet KJ. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: a survey of patients receiving antiretroviral therapy. J Am Pharmacists Association. 2021;61(2):e75-9.
Google Scholar
Ryder PT, Meyerson BE, Coy KC, von Hippel CDJ. Pharmacists’ perspectives on HIV testing in community pharmacies. J Am Pharmacists Association. 2013;53(6):595–600.
Google Scholar
McCree DH, Byrd KK, Johnston M, Gaines M, Weidle PJ. Roles for pharmacists in the “ending the HIV epidemic: a plan for America” initiative. Public Health Rep. 2020;135(5):547–54.
Google Scholar
Crawford ND, Albarran T, Chamberlain A, Hopkins R, Josma D, Morris J, et al. Willingness to discuss and screen for pre-exposure prophylaxis in pharmacies among men who have sex with men. J Pharm Pract. 2021;34(5):734–40.
Google Scholar
Zhao A, Dangerfield DT, Nunn A, Patel R, Farley JE, Ugoji CC, et al. Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review. AIDS Behav. 2022;26(5):1377–92.
Google Scholar
Weidle PJ, Lecher S, Botts LW, Jones L, Spach DH, Alvarez J, et al. HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection. J Am Pharmacists Association. 2014;54(5):486–92.
Google Scholar
Crawford ND, Dean T, Rivera AV, Guffey T, Amesty S, Rudolph A, et al. Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach. Public Health Rep. 2016;131(Suppl 1):139–46.
Google Scholar
Sawkin M, Shah M. Development of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis clinic at an urban community clinic. J Am Pharm Assoc. 2016;56:e48.
Crawford ND, Lewis CF, Moore R, Pietradoni G, Weidle P. Examining the multilevel barriers to pharmacy-based HIV prevention and treatment services. Sex Transm Dis. 2022;49(11S):S22.
Google Scholar
Centers for Disease Control and Prevention. HIV surveillance report, 2019, vol. 32. 2021. Available from:
link
